ProjectGORE VSX 20-03 – Evaluation of the use of the “GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface”…
Basic data
Acronym:
GORE VSX 20-03
Title:
Evaluation of the use of the “GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface” (VSX), a device manufactured by W. L. Gore & Associates, Inc. (“Device”)
Duration:
12/07/2021 to 09/06/2031
Abstract / short description:
Evaluation of the use of the “GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface” (VSX), a device manufactured by W. L. Gore & Associates, Inc. (“Device”)
Involved staff
Managers
Faculty of Medicine
University of Tübingen
University of Tübingen
Cluster of Excellence: Image-Guided and Functionally Instructed Tumor Therapies (iFIT)
Centers or interfaculty scientific institutions
Centers or interfaculty scientific institutions
Contact persons
Faculty of Medicine
University of Tübingen
University of Tübingen
Department of Diagnostic and Interventional Radiology
Department of Radiology, Hospitals and clinical institutes, Faculty of Medicine
Department of Radiology, Hospitals and clinical institutes, Faculty of Medicine
Local organizational units
Department of Diagnostic and Interventional Radiology
Department of Radiology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Funders
Putzbrunn, Bayern, Germany